Combining BKM120 with doxorubicin increased benefits, although these did not reach statistical significance.
← all excerpts
Efficacy of phosphatidylinositol-3 kinase inhibitors in a primary mouse model of undifferentiated pleomorphic sarcoma.
1
—
—
Combining BKM120 with doxorubicin increased benefits, although these did not reach statistical significance.